Cochlear implantation for single-sided deafness after COVID-19 hospitalization

Cochlear Implants Int. 2021 Nov;22(6):353-357. doi: 10.1080/14670100.2021.1936364. Epub 2021 Jun 19.

Abstract

Introduction: Understanding the clinical manifestations of the coronavirus disease (COVID-19) has become an urgent objective in the research community. Amongst the emerging neurologic complications is sensorineural hearing loss. While several cases of hearing loss amongst COVID-19 patients have been reported, the management of these patients has yet to be discussed and determined. Herein we present cochlear implant outcomes for a patient who suffered from unilateral sensorineural hearing loss after a prolonged hospital course for COVID-19.

Methods: A patient who was hospitalized for COVID-19 for one month and subsequently developed unilateral profound sensorineural hearing loss underwent cochlear implantation for single-sided deafness. His COVID-19 hospital course was reviewed in detail. Speech perception and audiometric assessments were used to evaluate cochlear implant outcomes.

Results: After cochlear implantation, the patient demonstrated improved speech perception on the implanted side and decreased tinnitus within 1 month of activation.

Conclusions: Cochlear implantation may be an appropriate intervention for patients who suffer from severe sensorineural hearing loss following infection with COVID-19.

Keywords: COVID-19; Cochlear implantation; Sensorineural hearing loss.

MeSH terms

  • COVID-19*
  • Cochlear Implantation*
  • Deafness* / etiology
  • Deafness* / surgery
  • Hearing Loss, Unilateral* / etiology
  • Hearing Loss, Unilateral* / surgery
  • Hospitalization
  • Humans
  • SARS-CoV-2